Large mediastinal tumor mass as a prognostic factor in Hodgkin's lymphoma: Is the definition on the basis of a chest radiograph in the era of CT obsolete?;Groβer Mediastinaltumor als prognostischer Faktor bei Hodgkin-Lymphom: Ist die Definition auf Basis der Thoraxröntgenaufname im CT-Zeitalter überholt?

Strahlentherapie und Onkologie

Volumn 188, Issue 11, 2012, Pages 1020-1024

  Kriz, J ^a   Mueller, R P ^b   Mueller, H ^b   Kuhnert, G ^b   Engert, A ^b   Kobe, C ^b   Haverkamp, U ^a   Eich, H T ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Differential diagnosis; Lymph nodes; Mediastinal neoplasms; Prognosis; Risk factors

Indexed keywords

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER RISK; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC VALUE; FEMALE; HODGKIN DISEASE; HUMAN; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; MEDIASTINUM TUMOR; PRACTICE GUIDELINE; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY; THORAX RADIOGRAPHY; TUMOR VOLUME;

ADOLESCENT; ADULT; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; HODGKIN DISEASE; HUMANS; LYMPHATIC METASTASIS; MALE; MEDIASTINAL NEOPLASMS; MEDIASTINUM; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 84867977959     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-012-0163-7     Document Type: Article

References (11)

1. Mauch P, Goodman R, Hellmann S (1978) The significance of mediastinal involvement in early stage Hodgkin's disease. Cancer 42:1039-1045
2. Lee CKK, Bloomfield CD, Goldman AI et al (1980) Prognostic significance of mediastinal involvement in Hodgkin's disease treated with curative chemotherapy. Cancer 46:2403-2409
3. Zabel-du Bois A, Nill S, Ulrich S et al (212) Dosimetric integration of daily mega-voltage cone beam CT for image-guided intensitiy modulated radiotherapy. Strahlenther Onkol 188(2):120-126
4. Engert A, Plütschow A, Eich HT et al (2010) Reduced treatment intensity in patients with early stage Hodgkin's Lymphoma. N Engl J Med 363:640-652
5. Eich HT, Diehl V, Görgen H et al (2010) Intensified chemotherapy and dose reduced Involved-Field Radiotherapy in patients with early unfavourable Hodgkin's Lymphoma: final analysis of the German Hodgkin Study Group HD11 Trial. J Clin Oncol 28:4199-4206
6. Kobe C, Dietlein M et al (2008) Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma. Blood 112(10):3989-3994
7. Engert A, Haverkamp H et al (2012) Reduced-intensity of chemotherapy and PET-guided radiotherapy in patients with advanced stage hodgkin lymphoma: an open-label, randomized phase 3 trial. Lancet 379:1791-1799
8. Eich HT, Kriz J, Müller R-P (2011) Evolution of radiation therapy within the German Hodgkin Study Group Trials. J Natl Compr Canc Netw 9(9):1073-1080
9. Bradley BM, Carrington JA, Lawrance WD et al (1999) Assessment and significance of mediastinal bulk in Hodgkin's disease: Comparison between computed tomography and chest radiograph. J Clin Oncol 17(8):2493-2498
10. Hopper K, Diehl L, Lynch J et al (1991) Mediastinal bulk in Hodgkin disease - method of measurement versus prognosis. Invest Radiol 26(12):1101-1110
11. Hui S, Lusczek E, DeFor T et al (2012) Three dimensional patient setup errors at different treatment sites measured by Tomotherapy megavoltage CT. Strahlenther Onkol 188(4):346-352